This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Michael T. Osterholm, PhD, MPH; Trudy V. Murphy, MD

JAMA. 1984;251(18):2408-2409.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Systemic disease caused by Hemophilus influenzae type b is of major clinical and public health importance in this country. Five epidemiologic studies to date have demonstrated the increased risk of secondary disease among household contacts younger than 4 years, and outbreaks of disease have been reported in child day-care facilities.¹ Initial hopes for preventing both primary and secondary disease with vaccination were dashed when a promising vaccine failed to provide protection to infants. While efforts have continued in the development of improved vaccines, a search has been initiated for a prophylactic antibiotic that would prevent secondary disease.

The study by Band and colleagues² in this issue presents the only available data addressing the question of efficacy of antimicrobial prophylaxis for disease caused by H influenzae. These data were presented at a national meeting in November 1981³ and were the basis for recommendations published in 1982 by the American . . . [Full Text PDF of this Article]

Author Affiliations
Minnesota Department of Health Minneapolis; University of Texas Health Science Center Dallas

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?